A photo of Russel Hirsch.

Director, Cardiac Catheterization Laboratory

Director, Pulmonary Hypertension Service

Professor, UC Department of Pediatrics


Board Certified

Best Doctors logo

About Me

Clinical Interests

Percutaneous interventions for the palliation or treatment of congenital heart disease; treatment of all forms of pediatric pulmonary hypertension; interventional catheterization; pulmonary hypertension; General Cardiology Outpatient Clinic

Research Interests

Device closure of congenital heart defects; feasibility of covered stent use in coarctation of the aorta; pulmonary vascular complications associated with congenital diaphragmatic hernia and chronic lung disease; cardiac manifestations of post bone-marrow transplant thrombotic microangiopathy; non-invasive evaluation of pulmonary hypertension in pediatric age patients; validation of new methods for assessing oxygen consumption in the cardiac catheterization laboratory

Academic Affiliation

Professor, UC Department of Pediatrics


Heart, Hereditary Hemorrhagic Telangiectasia, Pulmonary Hypertension, Catheterization and Intervention, Bronchopulmonary Dysplasia BPD

My Education

MBChB: University of Cape Town, Cape Town, South Africa.

Residency: St. Louis Children's Hospital, St. Louis, MO.

Fellowship: St. Louis Children's Hospital and Washington University School of Medicine, St. Louis, MO.

Certification: Pediatrics, 1994, 2002 (renew); Pediatric Cardiology, 1998, 2005.

My Publications

Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al. Blood. 2020; 26:S138-S138.

Use of Continuous Dexmedetomidine at Home for Nearly Three Years in a Young Woman with End-Stage Cyanotic Congenital Heart Disease and Cyclic Vomiting. Thienprayoon, R; Meyer, M; Flint, H; Weidner, N; Hirsch, R. Journal of Palliative Medicine. 2019; 22:1289-1292.

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension. Ivy, DD; Feinstein, JA; Yung, D; Mullen, MP; Kirkpatrick, EC; Hirsch, R; Austin, ED; Fineman, J; Truong, U; Solum, D; et al. Pulmonary Circulation. 2019; 9:2045894019856471-204589401985647.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Rhodes, CJ; Batai, K; Bleda, M; Haimel, M; Southgate, L; Germain, M; Pauciulo, MW; Hadinnapola, C; Aman, J; Girerd, B; et al. The Lancet Respiratory Medicine. 2019; 7:227-238.

Rare Cause for a Continuous Murmur: Large Left Coronary Artery to Coronary Sinus Fistula. Baskar, S; Hirsch, R; Powell, AW; Tinker, D; Kimball, TR. World Journal for Pediatric and Congenital Hearth Surgery. 2018; 9:705-707.

Incidence and Mortality of Adults With Pulmonary Hypertension and Congenital Heart Disease. Schwartz, SS; Madsen, N; Laursen, HB; Hirsch, R; Olsen, MS. American Journal of Cardiology. 2018; 121:1610-1616.

Life-threatening airway bleeding after palliation of single ventricle congenital heart disease. Averin, K; Byrnes, JW; Benscoter, DT; Whiteside, W; DeSena, H; Hirsch, R; Goldstein, BH. Heart. 2018; 104:254-260.

Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients. Dandoy, CE; Jodele, S; Paff, Z; Hirsch, R; Ryan, TD; Jefferies, JL; Cash, M; Rotz, S; Pate, A; Taylor, MD; et al. Pediatric Blood and Cancer. 2017; 64:e26513-e26513.

The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults. Rotz, SJ; Ryan, TD; Jodele, S; Jefferies, JL; Lane, A; Pate, A; Hirsch, R; Hlavaty, J; Levesque, AE; Taylor, MD; et al. Bone Marrow Transplantation. 2017; 52:1171-1179.

Ventricular Septal Defect Creation: A Viable Option to Decompress a Large Non-Systemic Left Ventricle in a Fontan Patient. Elderie, A; Reddy, A; Zafar, F; Hirsch, R; Morales, DL S. World Journal for Pediatric and Congenital Hearth Surgery. 2017; 8:400-403.